SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing intense retail activity fueled by anticipation of a potential buyout and upcoming clinical data, creating a significant short squeeze setup that the community is actively tracking. Investors are discussing the high short interest and lack of available shares to borrow, while debating whether current price levels are justified by potential long-term breakthroughs in oncology.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently in the spotlight following the announcement of three new NASA launch contracts, which reinforces its credibility as a reliable, institutional-grade partner in the space infrastructure sector. Despite recent volatility and broader sector pressure linked to SpaceX liquidity dynamics, the community remains intensely focused on the company's long-term execution, backlog growth, and the upcoming Neutron rocket development as key catalysts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant upward momentum and trending interest as retail investors pile into the stock, fueled by intense speculation regarding its potential inclusion in the Russell 1000 index. Community discourse remains highly active, with long-term shareholders highlighting anticipation for upcoming clinical and commercial catalysts, while simultaneously clashing with short sellers over the stock's future direction.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is attracting significant attention as investors react to the company's strategic pivot to discontinue internal discovery programs and close its Alabama facility in favor of an external innovation model. The community is actively debating the implications of this cost-cutting measure, with many speculating that cleaning up the balance sheet could position the company as a more attractive acquisition target.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant market interest as community members speculate on the potential for a major government satellite contract, driving expectations for a short squeeze against a high volume of bearish positions. The discourse is heavily focused on the company's technical edge in direct-to-device connectivity compared to competitors, with investors viewing current price action as a strategic entry point before anticipated operational milestones.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending following the major announcement of a tax-free spin-off, which will separate NBCUniversal and Sky into an independent public company. Community members are actively debating the long-term strategic benefits of this split, focusing on whether the move effectively unlocks value for shareholders and how it impacts the competitive positioning of its remaining technology and broadband business.

Iridium Communications, Inc. operates as a commercial provider of communications services offering true global coverage, connecting people, organizations and assets to and from anywhere, in real time. It offers its services to businesses, the U.S. and foreign governments, non-governmental organizations, and consumers via satellite network, which has an architecture of operational satellites with in-orbit spares and related ground infrastructure. Its products include personal communicators, messengers, and trackers, satellite phones, push-to-talk-devices, broadband terminals, midband terminals, external antennas, docking stations, apps, accessories and developer tools & resources. The company was founded in 2000 and is headquartered in McLean, VA.

Iridium Communications Inc

Iridium Communications is currently the subject of intense buyout speculation, with market chatter linking the company to potential acquirers like SpaceX or Amazon as investors highlight the strategic value of its globally harmonized L-band spectrum. While some community members argue that Iridiums critical role in government and defense infrastructure makes an outright sale unlikely, the stock remains a central focus for traders betting on further consolidation in the satellite sector.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is currently trending as investors debate whether the stock's significant decline has created a deep-value opportunity or if the company's heavy debt and competitive pressures from the satellite industry remain major risks. While community sentiment is deeply polarized between those betting on a potential short squeeze fueled by massive institutional insider buying and those who view the downtrend as a reflection of long-term structural obsolescence, the stock is seeing heightened volatility as traders weigh the company's massive share buyback programs against its eroding subscriber base.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors debate its valuation, specifically questioning whether it should be viewed as a traditional social media platform or a high-growth data infrastructure play for AI training. Community sentiment is deeply divided, with traders focused on structural support levels and potential short-term volatility, while others speculate on long-term monetization potential through data licensing deals.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is attracting intense community attention as it prepares for inclusion in the Russell 2000 and 3000 indexes, sparking debates between investors looking for long-term potential in defense technology and those concerned about ongoing volatility and share dilution. While some traders view the recent price decline as a strategic liquidity reset and a prime entry point for institutional accumulation, others remain cautious, highlighting the stock's recent downward momentum and the broader cooling of high-beta tech sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYCN 

S-4/A dated 6/9/26
“On March 19, 2026, Terrence McGuire on behalf of the board of directors of Tisento, contacted Dr. Graul with an unsolicited offer to purchase all equity securities of Tisento beneficially owned by Cyclerion … the Cyclerion Board determined that the purchase price offered in the Tisento Proposal was not an acceptable price for 10% of the equity interests of Tisento … The Cyclerion Board directed … Cyclerion’s management to identify potential transactions and interested counterparties for the sale of the equity securities of Tisento beneficially owned by Cyclerion.“

7/31/23 Cyclerion PR
“Tisento is launching with an $81 million Series A financing … CYCLERION received 10 percent equity ownership in Tisento with anti-dilution protection through $100 million in post-money valuation, as well as the right to purchase additional Tisento equity in the future. ”

1/8/26 Tisento PR
“company expects to report top-line data from the study in the fourth quarter of 2026.”

Paul

StockTwits for iOS

Cyclerion Therapeutics Inc

 

S-4/A dated 6/9/26
“On March 19, 2026, Terrence McGuire on behalf of the board of directors of Tisento, contacted Dr. Graul with an unsolicited offer to purchase all equity securities of Tisento beneficially owned by Cyclerion … the Cyclerion Board determined that the purchase price offered in the Tisento Proposal was not an acceptable price for 10% of the equity interests of Tisento … The Cyclerion Board directed … Cyclerion’s management to identify potential transactions and interested counterparties for the sale of the equity securities of Tisento beneficially owned by Cyclerion.“

7/31/23 Cyclerion PR
“Tisento is launching with an $81 million Series A financing … CYCLERION received 10 percent equity ownership in Tisento with anti-dilution protection through $100 million in post-money valuation, as well as the right to purchase additional Tisento equity in the future. ”

1/8/26 Tisento PR
“company expects to report top-line data from the study in the fourth quarter of 2026.”

CEMBP

$CYCN 

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=320119952&amp;type=HTML&amp;symbol=CYCN&amp;cdn=b881e5ad90bf057af265b23a599d866c&amp;companyName=Cyclerion+Therapeutics+Inc.&amp;formType=S-4%2FA&amp;formDescription=%5BAmend%5D+Registration+of+securities%2C+business+combinations&amp;dateFiled=2026-06-09

https://ir.cyclerion.com/news-releases/news-release-details/tisento-launches-81-million-top-tier-investor-syndicate-and

https://www.tisentotx.com/news/tisento-therapeutics-completes-enrollment-in-prizm-a-global-phase-2b-study-of-zagociguat-for-the-treatment-of-melas

will not take place unless Proposal Nos. 1, 2, and 3 are approved by Cyclerion shareholders and the Merger is consummated. The amendment to the Cyclerion Articles to effect a reverse stock split of Cyclerion's issued and outstanding common stock, will not take place unless Proposal Nos.

Quotemedia

Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment - - Tisento Developing Zagociguat in MELAS*, a Rare Primary Mitochondrial Disease with No Approved Therapies, Leveraging Extensive Preclinical and Clinical Data Generated by Cyclerion

Cyclerion Therapeutics, Inc.

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets | Cyclerion Therapeutics, Inc.

Company Expects to Report Topline Data in Q4 2026 CAMBRIDGE, Mass. - Tisento Therapeutics today announced that the global Phase 2b PRIZM study is fully enrolled. PRIZM is evaluating zagociguat - a once-daily, oral investigational medicine - as a treatment for the rare mitochondrial disea